Long term Coptidis Rhizoma intake induce gastrointestinal emptying inhibition and colon barrier weaken via bitter taste receptors activation in mice.

IF 6.7 1区 医学 Q1 CHEMISTRY, MEDICINAL
Zhizhongbin Wu, Wei Yang, Tianyue Wu, Yulin Liu, Yu Pu, Weiqing Hu, Yunbin Jiang, Jifen Zhang, Huifeng Zhu, Xuegang Li, Shan Feng
{"title":"Long term Coptidis Rhizoma intake induce gastrointestinal emptying inhibition and colon barrier weaken via bitter taste receptors activation in mice.","authors":"Zhizhongbin Wu, Wei Yang, Tianyue Wu, Yulin Liu, Yu Pu, Weiqing Hu, Yunbin Jiang, Jifen Zhang, Huifeng Zhu, Xuegang Li, Shan Feng","doi":"10.1016/j.phymed.2024.156292","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Coptidis Rhizoma, a classic bitter traditional Chinese medicine, can lead to digestive dysfunction when long-term use according to traditional experience. Bitter taste receptors have been found to regulate gastrointestinal smooth muscle contraction. Coptidis Rhizoma alkaloids are potential agonists for bitter taste receptors, but whether they can induce gastrointestinal dysfunction via bitter taste receptors is not clear.</p><p><strong>Purpose: </strong>The purpose of this study is to elucidate whether long-term Coptidis Rhizoma decoction/berberine intake can affect gastrointestinal function via bitter taste receptors.</p><p><strong>Methods: </strong>Firstly, mice were orally administered Coptidis Rhizoma decoction (or berberine) for 8 weeks, then their appetite, gastrointestinal emptying function, colon barrier function, and gut microbiota homeostasis were evaluated. Subsequently, isolated intestine, molecular docking, calcium release, and immunofluorescence co-localization experiments were applied to explore the mechanism of Coptidis Rhizoma decoction (or berberine) inhibition effects on gastrointestinal motility. Finally, transmembrane resistance, scratch assay, tight junction and cytoskeletal protein immunofluorescence staining were conducted to verify that the bitter taste receptor is the target for Coptidis Rhizoma decoction (or berberine) to damage the colon barrier function.</p><p><strong>Result: </strong>Long-term Coptidis Rhizoma decoction (or berberine) intake can reduce appetite, inhibit gastrointestinal contractions, disrupt bacterial balance and colon barrier function in mice. Further mechanistic studies have shown that the alkaloids of Coptidis Rhizoma are agonists for bitter taste receptors, which can promote α-gustducin binding to CHRM3 by activating bitter taste receptors, finally inhibiting gastrointestinal smooth muscle contraction. In addition, Coptidis Rhizoma decoction (or berberine) can activate bitter taste receptors and its downstream pathways PKCβ/RhoA/ROCK1/MLC-2, reshape skeletal proteins, downregulate tight junction protein expression, and ultimately disrupt colon barrier function.</p><p><strong>Conclusions: </strong>Long term Coptidis Rhizoma intake induce gastrointestinal emptying inhibition and colon barrier weaken via bitter taste receptor activation in mice.</p>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"136 ","pages":"156292"},"PeriodicalIF":6.7000,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phytomedicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.phymed.2024.156292","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Coptidis Rhizoma, a classic bitter traditional Chinese medicine, can lead to digestive dysfunction when long-term use according to traditional experience. Bitter taste receptors have been found to regulate gastrointestinal smooth muscle contraction. Coptidis Rhizoma alkaloids are potential agonists for bitter taste receptors, but whether they can induce gastrointestinal dysfunction via bitter taste receptors is not clear.

Purpose: The purpose of this study is to elucidate whether long-term Coptidis Rhizoma decoction/berberine intake can affect gastrointestinal function via bitter taste receptors.

Methods: Firstly, mice were orally administered Coptidis Rhizoma decoction (or berberine) for 8 weeks, then their appetite, gastrointestinal emptying function, colon barrier function, and gut microbiota homeostasis were evaluated. Subsequently, isolated intestine, molecular docking, calcium release, and immunofluorescence co-localization experiments were applied to explore the mechanism of Coptidis Rhizoma decoction (or berberine) inhibition effects on gastrointestinal motility. Finally, transmembrane resistance, scratch assay, tight junction and cytoskeletal protein immunofluorescence staining were conducted to verify that the bitter taste receptor is the target for Coptidis Rhizoma decoction (or berberine) to damage the colon barrier function.

Result: Long-term Coptidis Rhizoma decoction (or berberine) intake can reduce appetite, inhibit gastrointestinal contractions, disrupt bacterial balance and colon barrier function in mice. Further mechanistic studies have shown that the alkaloids of Coptidis Rhizoma are agonists for bitter taste receptors, which can promote α-gustducin binding to CHRM3 by activating bitter taste receptors, finally inhibiting gastrointestinal smooth muscle contraction. In addition, Coptidis Rhizoma decoction (or berberine) can activate bitter taste receptors and its downstream pathways PKCβ/RhoA/ROCK1/MLC-2, reshape skeletal proteins, downregulate tight junction protein expression, and ultimately disrupt colon barrier function.

Conclusions: Long term Coptidis Rhizoma intake induce gastrointestinal emptying inhibition and colon barrier weaken via bitter taste receptor activation in mice.

求助全文
约1分钟内获得全文 求助全文
来源期刊
Phytomedicine
Phytomedicine 医学-药学
CiteScore
10.30
自引率
5.10%
发文量
670
审稿时长
91 days
期刊介绍: Phytomedicine is a therapy-oriented journal that publishes innovative studies on the efficacy, safety, quality, and mechanisms of action of specified plant extracts, phytopharmaceuticals, and their isolated constituents. This includes clinical, pharmacological, pharmacokinetic, and toxicological studies of herbal medicinal products, preparations, and purified compounds with defined and consistent quality, ensuring reproducible pharmacological activity. Founded in 1994, Phytomedicine aims to focus and stimulate research in this field and establish internationally accepted scientific standards for pharmacological studies, proof of clinical efficacy, and safety of phytomedicines.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信